do glp-1 cause cancer Glucagon-like peptide 1 receptor agonists and risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research The effect of GLP-1R agonists

In this guide, well explore practical strategies for enhancing GLP-1 levels with higher satiety and nutrient-dense foods

However, as of early 2026 , the FDA has cracked down on this practice

Not only are there currently millions of people on these compounded drugs, all of whom would have to get new prescriptions to switch over to brand-name ones, but the market is ever-growing as these drugs gain new approved uses, like sleep apnea

Reports also show that when people taking these medications follow healthy diet plans, they tend to eat more protein and fewer added sugars

Concerns include reports of adverse events, some requiring hospitalization, that may be related to dosing errors or doses beyond what is in the FDA-approved drug label, which means using more product in a single dose, taking doses more frequently or increasing the amount more quickly (titration schedule)

It supports satiety